N-Acetyl Cysteine showed improved dopamine transporter binding in a 42-patient Parkinson’s study. It’s the strongest evidence in our research — but it has major limitations.
content by CRI-ONE Blog
content by CRI-ONE Blog
N-Acetyl Cysteine showed improved dopamine transporter binding in a 42-patient Parkinson’s study. It’s the strongest evidence in our research — but it has major limitations.